- Carleton’s Registration Instructions and Form
- Carleton’s rDNA Registration Amendment Form
- Carleton’s form to request exemption of rDNA experiments
NIH and biosafety information
- NIH Biosafety/Institutional Biosafety Committees [link to Institutional Biosafety Committee Registration Management System (IBC-RMS)]
- Biosafety Guidance and Resources lists numerous additional resources (links to CDC, ABSA, AIHA, and more, including a Biosafety Discussion List)
- FAQs on NIH Guidelines such as on Incident Reporting, Toxin Experiments, IBC Administration
- FAQs on exempt experiments
- IBC Approval Requirements: How to classify your experiments
- Overview of the NIH Guidelines by Dr. Kathryn Harris, in the Office of Science Policy, 2009
- Carleton’s Recombinant DNA Training
- Haverford Recombinant DNA Training
Applicable regulations and guidelines
- CDC/NIH: Biosafety in Microbiological and Biomedical Laboratories, current edition.
- Department of Transportation (DOT): 49 CFR Parts 171-177, Hazardous Materials Regulations.
- International Air Transport Association (IATA): Dangerous Goods Regulations.
- NIH: NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
- OSHA: 29 CFR 1910.1030, Bloodborne Pathogens.
- U.S. Public Health Service (USPHS): 42 CFR Part 72, Interstate Transportation of Etiologic Agents.
- U.S. Department of Agriculture (USDA): 7 CFR Part 331 and 9 CFR Part 121, Agricultural Bioterrorism Protection Act of 2002; Possession, Use and Transfer of Select Agents and Toxins, Final Rule.
- Department of Health and Human Services (DHHS): 42 CFR Parts 72 and 73, Office of Inspector General and 42 CFR Part 1003 Possession, Use and Transfer of Select Agents and Toxins, Final Rule.
- USA Patriot Act of 2001.